Davide Danovi

Dr. Davide Danovi is leading the Cell Phenotyping Unit at King's College London in the framework of the HipSci project, funded by the Wellcome Trust and MRC. Prior to this, he was principal scientist at Progenitor Labs, a novel biotechnology company founded to isolate drugs for regenerative medicine using innovative stem cell technologies. Before, he worked with Prof. Austin Smith and Dr. Steve Pollard at the University of Cambridge and at University College London where he developed a live image based chemical screening platform to isolate compounds active on human neural stem cells from normal or brain tumour samples. He holds an MD from University of Milan and a PhD in Molecular Oncology from the European Institute of Oncology where he demonstrated the causative role of the HdmX protein in human cancer.